vVardis Raises $175 Million Ahead of NYSE IPO, Set to Trade Under 'VVVV'

Dental health firm vVardis has successfully raised $175 million in capital prior to its initial public offering on the New York Stock Exchange (NYSE). The company is slated to begin trading under the ticker symbol 'VVVV', having priced 9.72 million shares at $18 each. Co-founders and Co-CEOs Dr. Haley Abivardi and Dr. Goly Abivardi are expected to discuss the company's decision to go public on NYSE Live. vVardis is known for its commercially available peptide-containing formulation designed to treat early cavities without drilling.